Shanghai Bio-heart Biological Technology Co., Ltd.
2185.HK
Price:
$6.3
Market Cap:
$1.35B
Shanghai Bio-heart Biological Technology Co., Ltd. operates as an interventional cardiovascular device company in the People's Republic of China. The company focuses on the provision of bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies for the treatment of coronary artery diseases and uncontrolled and resistant hypertension. It is developing Bioheart, a BRS system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a multi-electrode RDN product candidate; and drug coated balloon, a sirolimus drug-eluting balloon catheter designed for instent restenosis. The company has collaboration agreements with Terumo (China) I...[Read more]
Industry
Biotechnology
IPO Date
2021-12-23
Stock Exchange
HKSE
Ticker
2185.HK
PE Ratio
[-15.75]
ROE
[-15.70%]
Current Ratio
[12.65]
Dividend Yield
[0%]
Enterprise Value
[1.17B]
Dividend History
The ROE as of December 2025 (TTM) for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) is -15.70%
According to Shanghai Bio-heart Biological Technology Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -15.70%. This represents a change of 105.07% compared to the average of -7.65% of the last 4 quarters.
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Historical ROE (quarterly & annually)
How has 2185.HK ROE performed in the past?
The mean historical ROE of Shanghai Bio-heart Biological Technology Co., Ltd. over the last ten years is -36.29%. The current -15.70% ROE has changed -56.75% with respect to the historical average. Over the past ten years (40 quarters), 2185.HK's ROE was at its highest in in the June 2021 quarter at 0%. The ROE was at its lowest in in the June 2022 quarter at -21.63%.
Average
-36.29%
Median
-31.60%
Minimum
-63.04%
Maximum
-13.32%
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) ROE by Quarter and Year
Discovering the peaks and valleys of Shanghai Bio-heart Biological Technology Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = -13.32%
Minimum Annual Increase = -48.73%
Minimum Annual ROE = -63.04%
| Year | ROE | Change |
|---|---|---|
| 2024 | -13.32% | -48.73% |
| 2023 | -25.97% | -3.42% |
| 2022 | -26.89% | -25.92% |
| 2021 | -36.30% | -30.52% |
| 2020 | -52.25% | -17.12% |
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Average ROE
How has 2185.HK ROE performed in the past?
The current ROE of Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.06%
5-year avg
-30.95%
10-year avg
-36.29%
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) ROE vs. Peers
How is 2185.HK’s ROE compared to its peers?
Shanghai Bio-heart Biological Technology Co., Ltd.’s ROE is greater than SinoMab BioScience Limited (-66.18%), less than HighTide Therapeutics Inc (-0.08%), greater than Mabpharm Limited (-29.27%), less than Immunotech Biopharm Ltd (287.10%), greater than Zhaoke Ophthalmology Limited (-15.44%), greater than Cutia Therapeutics (-54.56%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), greater than C-MER Medical Holdings Limited (-6.56%), greater than 3D Medicines Inc. (-22.45%), less than Frontage Holdings Corporation (1.14%),
| Company | ROE | Market cap |
|---|---|---|
| -66.18% | $1.82B | |
| -0.08% | $1.71B | |
| -29.27% | $2.47B | |
| 287.10% | $1.61B | |
| -15.44% | $1.72B | |
| -54.56% | $1.95B | |
| -59.45% | $1.28B | |
| -6.56% | $2.03B | |
| -22.45% | $1.25B | |
| 1.14% | $2.09B |
Build a custom stock screener for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Bio-heart Biological Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Shanghai Bio-heart Biological Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Shanghai Bio-heart Biological Technology Co., Ltd.'s ROE?
How is the ROE calculated for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)?
What is the highest ROE for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)?
What is the 3-year average ROE for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)?
What is the 5-year average ROE for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)?
How does the current ROE for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) compare to its historical average?